Assessment & Management of VTE: What the Community Pharmacist Needs to Know

HDPhA Invite October 26th 2022

Learning Objectives:

Upon successful completion of this presentation, healthcare professionals will be better able to:

-Review goals of therapy for DVT/PE treatment

-Review provoking factors for thrombosis & impact on treatment duration

-Review anticoagulant treatment options & monitoring parameters

-anticoagulant management with Paxlovid

Speaker

Stephanie Carlin is a thrombosis pharmacist at Hamilton Health Sciences in Hamilton, Ontario, Canada. She completed a Bachelor of Science in Pharmacy at the University of Toronto in 2010, followed by a Doctor of Pharmacy in 2015 at the University of Florida. She completed a general practice residency, followed by a thrombosis fellowship, both at the University of Toronto. In addition to her clinical work, she is involved in teaching undergraduate and graduate pharmacy and medical learners and has published a number of thrombosis-related research projects. She sits on the Ontario COVID-19 Science Advisory Table Drugs and Biologics Clinical Practice Guidelines Working Group and has co-authored a number of practice guidelines, including “Heparin Anticoagulation for Hospitalized Patients with COVID-19

Date:  October 26^th, 2022

Time: 6:30pm EST

Location: Sotiris Restaurant, 3135 Harvester Rd, Burlington, ON L7N 3N8